These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14925081)

  • 1. [Value of coli therapy in tuberculosis].
    KLAWITTER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 106(5):461-76. PubMed ID: 14925081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chlorination of drinking water, intestinal flora and infectious disease particularly tuberculosis].
    KEMPSKI HW
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 108(1-2):32-5. PubMed ID: 13051357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bases of coli-therapy].
    BAUMGARTEL T; ZAHN D
    Ther Ggw; 1955 Jul; 94(7):248-50. PubMed ID: 13267856
    [No Abstract]   [Full Text] [Related]  

  • 4. [The possibility of an oral substitution therapy with live functionating Escherichia coli].
    PEZOLD FA; TSCHECH H
    Dtsch Med Wochenschr; 1954 Jun; 79(24):961-5. PubMed ID: 13182878
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy of cancer with living colibacteria in Coutard's radiotherapy].
    NOACK H
    Arch Geschwulstforsch; 1952; 4(2):150-2. PubMed ID: 14934174
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of Escherichia coli with antagonist power in the treatment of certain digestive disorders in infants and children].
    DU PAN RM; NOVEL E
    Praxis; 1953 Oct; 42(43):901-6. PubMed ID: 13112010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rectal implantation coli bacteria, as a valuable factor for normalization of intestinal flora in enterocolitis].
    ALEXANDER M; KLUDAS M
    Arztl Wochensch; 1953 Nov; 8(47):1130-2. PubMed ID: 13104251
    [No Abstract]   [Full Text] [Related]  

  • 8. [The question of dysbacteria of the intestines].
    SIEDEK H
    Wien Klin Wochenschr; 1955 Mar; 67(12):206-8. PubMed ID: 14374432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacterium coli and the tuberculosis problem].
    FREUND W; MARTENS K
    Munch Med Wochenschr; 1951 Aug; 93(35):1720-1. PubMed ID: 14875014
    [No Abstract]   [Full Text] [Related]  

  • 10. [RESTITUTION OF THE INTESTINAL FLORA AS A SIGNIFICANT FACTOR IN TUBERCULOSIS THERAPY].
    SCHNEIDERHAN H
    Med Welt; 1963 Aug; 33():1647-51. PubMed ID: 14045624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic value of the addition of sodium benzoate to PAS in the treatment of tuberculosis; preliminary note].
    PARAF J; DESBORDES J; ROSENBERG E
    Bull Mem Soc Med Hop Paris; 1952 Jul 4-11; 68(24-25):912-4. PubMed ID: 12988032
    [No Abstract]   [Full Text] [Related]  

  • 12. [First observations on the therapeutic value of isonicotinic acid hydrazide in tuberculosis].
    MONALDI V
    Arch Tisiol Mal Appar Respir; 1952 Mar; 7(3):184-92. PubMed ID: 14944447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary report on therapeutic value of nicotinic acid hydrazine in the treatment of tuberculosis].
    MONALDI V
    Prog Med (Napoli); 1952 Apr; 8(7):193-8. PubMed ID: 14949133
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the value of chemotherapeutic agents in treatment of tuberculosis.
    CORPER HJ
    J Am Med Assoc; 1953 Apr; 151(17):1475-8. PubMed ID: 13034498
    [No Abstract]   [Full Text] [Related]  

  • 16. [Theories and therapeutic value of the use of combined tuberculostatics].
    HIRSCH J
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 116(3):268-74. PubMed ID: 13382719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dysbacteria of the colon in pulmonary tuberculosis and its relation to the autonomic nervous system].
    BLOEDNER CD
    Tuberkulosearzt; 1951 May; 5(5):289-93. PubMed ID: 14835860
    [No Abstract]   [Full Text] [Related]  

  • 18. The regulatory elements of the Mycobacterium tuberculosis gene Rv3881c function efficiently in Escherichia coli.
    Satchidanandam V; Amara RR; Uchil PD; Singh V
    FEMS Microbiol Lett; 2003 Jan; 218(2):365-70. PubMed ID: 12586418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous prime boosting based on intranasal delivery of non-pathogenic invasive Escherichia coli expressing MPT64, decreases Mycobacterium tuberculosis dissemination.
    Sali M; Dainese E; Morandi M; Zumbo A; Rocca S; Goussard S; Palù G; Grillot-Courvalin C; Delogu G; Manganelli R
    Vaccine; 2014 Jul; 32(32):4051-8. PubMed ID: 24886957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli.
    Oftung F; Mustafa AS; Husson R; Young RA; Godal T
    J Immunol; 1987 Feb; 138(3):927-31. PubMed ID: 2433335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.